{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:24:17Z","timestamp":1791995057156,"version":"4.4.0"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7_suppl_2","content-domain":{"domain":["neurology.org"],"crossmark-restriction":true},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2006,10,10]]},"DOI":"10.1212\/wnl.67.7_suppl_2.s8","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T14:45:05Z","timestamp":1336920305000},"update-policy":"https:\/\/doi.org\/10.1212\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":96,"title":["A proposed dual role of neuromelanin in the pathogenesis of Parkinson\u2019s disease"],"prefix":"10.1212","volume":"67","author":[{"given":"L.","family":"Zecca","sequence":"first","affiliation":[{"name":"From the Institute of Biomedical Technologies-Italian Research Council, Segrate, Italy (L.Z., F.A.Z., A.A.), National Institute of Metrology, Unit of Radiochemistry and Spectroscopy, Pavia, Italy (E.R.), and Newron Pharmaceuticals R&amp;D Department, Bresso (Milano), Italy (R.G.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. A.","family":"Zucca","sequence":"additional","affiliation":[{"name":"From the Institute of Biomedical Technologies-Italian Research Council, Segrate, Italy (L.Z., F.A.Z., A.A.), National Institute of Metrology, Unit of Radiochemistry and Spectroscopy, Pavia, Italy (E.R.), and Newron Pharmaceuticals R&amp;D Department, Bresso (Milano), Italy (R.G.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Albertini","sequence":"additional","affiliation":[{"name":"From the Institute of Biomedical Technologies-Italian Research Council, Segrate, Italy (L.Z., F.A.Z., A.A.), National Institute of Metrology, Unit of Radiochemistry and Spectroscopy, Pavia, Italy (E.R.), and Newron Pharmaceuticals R&amp;D Department, Bresso (Milano), Italy (R.G.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rizzio","sequence":"additional","affiliation":[{"name":"From the Institute of Biomedical Technologies-Italian Research Council, Segrate, Italy (L.Z., F.A.Z., A.A.), National Institute of Metrology, Unit of Radiochemistry and Spectroscopy, Pavia, Italy (E.R.), and Newron Pharmaceuticals R&amp;D Department, Bresso (Milano), Italy (R.G.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G.","family":"Fariello","sequence":"additional","affiliation":[{"name":"From the Institute of Biomedical Technologies-Italian Research Council, Segrate, Italy (L.Z., F.A.Z., A.A.), National Institute of Metrology, Unit of Radiochemistry and Spectroscopy, Pavia, Italy (E.R.), and Newron Pharmaceuticals R&amp;D Department, Bresso (Milano), Italy (R.G.F.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"1","volume":"38","year":"1960","unstructured":"Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 1960;38:1236\u20131239.","journal-title":"Klin Wochenschr"},{"key":"e_1_3_1_3_2","first-page":"7","volume":"73","year":"1961","unstructured":"Birkmayer W, Hornykiewicz O. The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wien Klin Wochenschr 1961;73:787\u2013788.","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6823561"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5321.2045"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.1.1.139"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0403495101"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.22.11869"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/cne.20098"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0741758.x"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0752583.x"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2003.01917.x"},{"key":"e_1_3_1_13_2","unstructured":"Crippa R Wang QJ Eisner M et al. Structure of human neuromelanin by X-ray diffraction: comparison with synthetics. Proc XVI Internat Pigment Cell Conference 1996."},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.1994.tb00061.x"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2003.08.009"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005072-196907000-00005"},{"key":"e_1_3_1_17_2","first-page":"489","year":"1974","unstructured":"Mann DM, Yates PO. Lipoprotein pigments\u2013their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain 1974;97:489\u2013498.","journal-title":"Brain"},{"key":"e_1_3_1_18_2","first-page":"71","volume":"5","year":"1986","unstructured":"Braak H, Braak E. Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum Neurobiol 1986;5:71\u201382.","journal-title":"Hum Neurobiol"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1994.62031097.x"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb08362.x"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410320713"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(96)00623-5"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0925-4439(95)00058-C"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(82)90390-1"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(88)90071-8"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3080808"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(88)90002-X"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-003-0080-0"},{"key":"e_1_3_1_29_2","first-page":"2403","volume":"37","year":"1978","unstructured":"Salazar M, Sokoloski TD, Patil PN. Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules. Fed Proc 1978;37:2403\u20132407.","journal-title":"Fed Proc"},{"key":"e_1_3_1_30_2","first-page":"500","volume":"17","year":"2003","unstructured":"Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, Lucius R. Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J 2003;17:500\u2013502.","journal-title":"FASEB J"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)03269-0"},{"key":"e_1_3_1_32_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1977.00500130053010"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.1.30"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(92)90719-P"},{"key":"e_1_3_1_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410430304"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/114.5.2283"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1992.tb08350.x"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.2.366"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2005.02.001"},{"key":"e_1_3_1_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0749.2004.00201.x"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.5.388"},{"key":"e_1_3_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0047-6374(83)90074-X"},{"key":"e_1_3_1_43_2","doi-asserted-by":"crossref","unstructured":"Zecca L Berg D Arzberger T et al. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 2005;","DOI":"10.1002\/mds.20550"},{"key":"e_1_3_1_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F"},{"key":"e_1_3_1_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(89)90390-X"},{"key":"e_1_3_1_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrn1537"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-004-0211-2"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/full\/10.1212\/WNL.67.7_suppl_2.S8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:49:13Z","timestamp":1711644553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.67.7_suppl_2.S8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,10]]},"references-count":46,"journal-issue":{"issue":"7_suppl_2","published-print":{"date-parts":[[2006,10,10]]}},"alternative-id":["10.1212\/WNL.67.7_suppl_2.S8"],"URL":"https:\/\/doi.org\/10.1212\/wnl.67.7_suppl_2.s8","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,10]]}}}